|
1
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Kent A: HPV vaccination and testing. Rev
Obstet Gynecol. 3:33–34. 2010.PubMed/NCBI
|
|
3
|
Kyung MS, Kim HB, Seoung JY, Choi IY, Joo
YS, Lee MY, Kang JB and Park YH: Tumor size and lymph node status
determined by imaging are reliable factors for predicting advanced
cervical cancer prognosis. Oncol Lett. 9:2218–2224. 2015.PubMed/NCBI
|
|
4
|
Bejerano G, Lowe CB, Ahituv N, King B,
Siepel A, Salama SR, Rubin EM, Kent WJ and Haussler D: A distal
enhancer and an ultraconserved exon are derived from a novel
retroposon. Nature. 441:87–90. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Katzman S, Kern AD, Bejerano G, Fewell G,
Fulton L, Wilson RK, Salama SR and Haussler D: Human genome
ultraconserved elements are ultraselected. Science. 317:9152007.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Calin GA, Liu CG, Ferracin M, Hyslop T,
Spizzo R, Sevignani C, Fabbri M, Cimmino A, Lee EJ, Wojcik SE, et
al: Ultraconserved regions encoding ncRNAs are altered in human
leukemias and carcinomas. Cancer Cell. 12:215–229. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Lujambio A, Portela A, Liz J, Melo SA,
Rossi S, Spizzo R, Croce CM, Calin GA and Esteller M: CpG island
hypermethylation-associated silencing of non-coding RNAs
transcribed from ultraconserved regions in human cancer. Oncogene.
29:6390–6401. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Braconi C, Valeri N, Kogure T, Gasparini
P, Huang N, Nuovo GJ, Terracciano L, Croce CM and Patel T:
Expression and functional role of a transcribed noncoding RNA with
an ultraconserved element in hepatocellular carcinoma. Proc Natl
Acad Sci USA. 108:786–791. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Wang C, Yan G, Zhang Y, Jia X and Bu P:
Long non-coding RNA MEG3 suppresses migration and invasion of
thyroid carcinoma by targeting of Rac1. Neoplasma. 62:541–549.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Pietruszewska W, Bojanowska-Poźniak K and
Kobos J: Matrix metalloproteinases MMP1, MMP2, MMP9 and their
tissue inhibitors TIMP1, TIMP2, TIMP3 in head and neck cancer: An
immunohistochemical study. Otolaryngol Pol. 70:32–43. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Mestdagh P, Fredlund E, Pattyn F, Rihani
A, van Maerken T, Vermeulen J, Kumps C, Menten B, de Preter K,
Schramm A, et al: An integrative genomics screen uncovers ncRNA
T-UCR functions in neuroblastoma tumours. Oncogene. 29:3583–3592.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Catucci I, Verderio P, Pizzamiglio S,
Manoukian S, Peissel B, Barile M, Tizzoni L, Bernard L, Ravagnani
F, Galastri L, et al: SNPs in ultraconserved elements and familial
breast cancer risk. Carcinogenesis. 30:544–546. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Ma J, Wang J, Fan W, Pu X, Zhang D, Fan C,
Xiong L, Zhu H, Xu N, Chen R and Liu S: Upregulated TIMP-1
correlates with poor prognosis of laryngeal squamous cell
carcinoma. Int J Clin Exp Pathol. 7:246–254. 2014.PubMed/NCBI
|
|
15
|
Lorente L, Martín MM, López P, Ramos L,
Blanquer J, Cáceres JJ, Solé-Violán J, Solera J, Cabrera J, Argueso
M, et al: Association between serum tissue inhibitor of matrix
metalloproteinase-1 levels and mortality in patients with severe
brain trauma injury. PLoS One. 9:e943702014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Ramer R, Fischer S, Haustein M, Manda K
and Hinz B: Cannabinoids inhibit angiogenic capacities of
endothelial cells via release of tissue inhibitor of matrix
metalloproteinases-1 from lung cancer cells. Biochem Pharmacol.
91:202–216. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Niewiarowska K, Pryczynicz A,
Dymicka-Piekarska V, Gryko M, Cepowicz D, Famulski W, Kemona A and
Guzińska-Ustymowicz K: Diagnostic significance of TIMP-1 level in
serum and its immunohistochemical expression in colorectal cancer
patients. Pol J Pathol. 65:296–304. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Rojiani MV, Ghoshal-Gupta S, Kutiyanawalla
A, Mathur S and Rojiani AM: TIMP-1 overexpression in lung carcinoma
enhances tumor kinetics and angiogenesis in brain metastasis. J
Neuropathol Exp Neurol. 74:293–304. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Ramos-DeSimone N, Hahn-Dantona E, Sipley
J, Nagase H, French DL and Quigley JP: Activation of matrix
metalloproteinase-9 (MMP-9) via a converging plasmin/stromelysin-1
cascade enhances tumor cell invasion. J Biol Chem. 274:13066–13076.
1999. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Morini M, Mottolese M, Ferrari N, Ghiorzo
F, Buglioni S, Mortarini R, Noonan DM, Natali PG and Albini A: The
alpha 3 beta 1 integrin is associated with mammary carcinoma cell
metastasis, invasion, and gelatinase B (MMP-9) activity. Int J
Cancer. 87:336–342. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Farina AR and Mackay AR: Gelatinase
B/MMP-9 in tumour pathogenesis and progression. Cancers (Basel).
6:240–296. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Groblewska M, Siewko M, Mroczko B and
Szmitkowski M: The role of matrix metalloproteinases (MMPs) and
their inhibitors (TIMPs) in the development of esophageal cancer.
Folia Histochem Cytobiol. 50:12–19. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Gupta GP and Massagué J: Cancer
metastasis: Building a framework. Cell. 127:679–695. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Klein CA: Cancer. The metastasis cascade.
Science. 321:1785–1787. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Sreekumar R, Sayan BS, Mirnezami AH and
Sayan AE: MicroRNA control of invasion and metastasis pathways.
Front Genet. 2:582011. View Article : Google Scholar : PubMed/NCBI
|
